HIV-1 Replication

In general terms, the replication cycle of lentiviruses, including HIV-1, closely resembles that of other retroviruses.1 There are, however, a number of unique aspects of HIV replication; for example, the HIVs and SIVs target receptors and coreceptors distinct from those used by other retroviruses. Lentiviruses encode a number of regulatory and accessory proteins not encoded by the genomes of the prototypical “simple” retroviruses. Of particular interest from the gene therapy perspective, lentiviruses possess the ability to productively infect some types of non-dividing cells. This chapter, while reiterating certain points discussed in Chapter 1, will attempt to focus on issues unique to HIV-1 replication.The HIV-1 genome encodes the major structural and non-structural proteins common to all replication-competent retroviruses (Fig. 1, and Chapter 1). From the 5′- to 3′-ends of the genome are found the gag (for group-specific antigen), pol (for polymerase), and env (for envelope glycoprotein) genes. The gag gene encodes a polyprotein precursor whose name, Pr55Gag, is based on its molecular weight. Pr55Gag is cleaved by the viral protease (PR) to the mature Gag proteins matrix (also known as MA or p17), capsid (CA or p24), nucleocapsid (NC or p7), and p6. Two spacer peptides, p2 and p1, are also generated upon Pr55Gag processing. The pol-encoded enzymes are initially synthesized as part of a large polyprotein precursor, Pr160GagPol, whose synthesis results from a rare frameshifting event during Pr55Gag translation. The individual pol-encoded enzymes, PR, reverse transcriptase (RT), and integrase (IN), are cleaved from Pr160GagPol by the viral PR.The envelope (Env) glycoproteins are also synthesized as a polyprotein precursor (Fig. 1). Unlike the Gag and Pol precursors, which are cleaved by the viral PR, the Env precursor, known as gp160, is processed by a cellular protease during Env trafficking to the cell surface. gp160 processing results in the generation of the surface (SU) Env glycoprotein gp120 and the transmembrane (TM) glycoprotein gp41. gp120 contains the determinants that interact with receptor and coreceptor, while gp41 not only anchors the gp120/gp41 complex in the membrane (Fig. 2), but also contains domains that are critical for catalyzing the membrane fusion reaction between viral and host lipid bilayers during virus entry. Comparison of env sequences from a large number of virus isolates revealed that gp120 is organized into five conserved regions (C1-C5) and five highly variable domains (V1-V5). The variable regions tend to be located in disulfide-linked loops. gp41 is composed of three major domains: the ectodomain (which contains determinants essential for membrane fusion), the transmembrane anchor sequence, and the cytoplasmic tail.In addition to the gag, pol, and env genes, HIV-1 also encodes a number of regulatory and accessory proteins. Tat is critical for transcription from the HIV-1 LTR and Rev plays a major role in the transport of viral RNAs from the nucleus to the cytoplasm. Vpu, Vif, Vpr and Nef have been termed “accessory” or “auxiliary” proteins to reflect the fact that they are not uniformly required for virus replication. The functions of these very interesting proteins will be discussed in more detail at the end of this chapter.HIV replication proceeds in a series of events that can be divided into two overall phases: “early” and “late” (Fig. 3).1 Although some events occur in a concerted or simultaneous fashion, the replication cycle can be viewed most simply as proceeding in an ordered, step-wise manner. In this chapter, each step in virus replication will be considered; additional information can be obtained from the more detailed reviews and primary references that are cited.

[1]  E. Freed,et al.  The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[2]  F. Bushman,et al.  Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain. , 2001, Acta crystallographica. Section D, Biological crystallography.

[3]  L. Chylack,et al.  Spatial and temporal dynamics of two alternatively spliced regulatory factors, lens epithelium-derived growth factor (ledgf/p75) and p52, in the nucleus , 2001, Cell and Tissue Research.

[4]  L. M. Mansky,et al.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase , 1995, Journal of virology.

[5]  C. Pauza Two bases are deleted from the termini of HIV-1 linear DNA during integrative recombination. , 1990, Virology.

[6]  M. Malim,et al.  The HIV-1 Rev protein. , 1998, Annual review of microbiology.

[7]  E. Freed,et al.  Genetic Evidence for an Interaction between Human Immunodeficiency Virus Type 1 Matrix and α-Helix 2 of the gp41 Cytoplasmic Tail , 2000, Journal of Virology.

[8]  J. Kaye,et al.  Nonreciprocal Packaging of Human Immunodeficiency Virus Type 1 and Type 2 RNA: a Possible Role for the p2 Domain of Gag in RNA Encapsidation , 1998, Journal of Virology.

[9]  Bertrand Friguet,et al.  Antiviral Activity of the Proteasome on Incoming Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.

[10]  A. Engelman In vivo analysis of retroviral integrase structure and function. , 1999, Advances in virus research.

[11]  F. Bushman,et al.  HIV cDNA integration: molecular biology and inhibitor development , 1996, AIDS.

[12]  J. A. Fyfe,et al.  Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Farber,et al.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.

[14]  E. Freed,et al.  HIV-1 gag proteins: diverse functions in the virus life cycle. , 1998, Virology.

[15]  B. Cullen HIV-1 Auxiliary Proteins: Making Connections in a Dying Cell , 1998, Cell.

[16]  M. Sudol,et al.  WW domains and retrovirus budding , 1996, Nature.

[17]  M A Wainberg,et al.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection , 1995, Microbiological reviews.

[18]  F. Bushman,et al.  Chromosome Structure and Human Immunodeficiency Virus Type 1 cDNA Integration: Centromeric Alphoid Repeats Are a Disfavored Target , 1998, Journal of Virology.

[19]  E. Freed,et al.  Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production , 1994, Journal of virology.

[20]  F. Bushman,et al.  Human Immunodeficiency Virus cDNA Metabolism: Notable Stability of Two-Long Terminal Repeat Circles , 2002, Journal of Virology.

[21]  E. Freed,et al.  p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease , 1995, Journal of virology.

[22]  H. Temin,et al.  Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Doms,et al.  CD4-Independent Infection by HIV-2 Is Mediated by Fusin/CXCR4 , 1996, Cell.

[24]  H. Kräusslich,et al.  In vitro assembly properties of wild-type and cyclophilin-binding defective human immunodeficiency virus capsid proteins in the presence and absence of cyclophilin A. , 1999, Virology.

[25]  A. Rein,et al.  Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication. , 1998, Trends in biochemical sciences.

[26]  Marc Parmentier,et al.  Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene , 1996, Nature.

[27]  M. Gonda,et al.  The trans-activator gene of HTLV-III is essential for virus replication , 1986, Nature.

[28]  R. Roeder,et al.  Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation , 1998, The EMBO journal.

[29]  J. Sodroski,et al.  Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Paul Shinn,et al.  HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots , 2002, Cell.

[31]  M. Malim,et al.  HIV-1 infection requires a functional integrase NLS. , 2001, Molecular cell.

[32]  V. Vogt,et al.  Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1 , 1995, Journal of virology.

[33]  J. Marsh,et al.  The numerous effector functions of Nef. , 1999, Archives of biochemistry and biophysics.

[34]  M. Lenburg,et al.  Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain , 1994, Cell.

[35]  D O Morgan,et al.  Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity , 1995, Journal of virology.

[36]  M. Malim,et al.  Evidence for a newly discovered cellular anti-HIV-1 phenotype , 1998, Nature Medicine.

[37]  L. Chylack,et al.  Transcriptional Regulation of the Antioxidant Protein 2 Gene, a Thiol-specific Antioxidant, by Lens Epithelium-derived Growth Factor to Protect Cells from Oxidative Stress* , 2001, The Journal of Biological Chemistry.

[38]  M. Resh,et al.  Differential membrane binding of the human immunodeficiency virus type 1 matrix protein , 1996, Journal of virology.

[39]  S. Harrison,et al.  Atomic structure of the ectodomain from HIV-1 gp41 , 1997, Nature.

[40]  P Bork,et al.  Comparison of ARM and HEAT protein repeats. , 2001, Journal of molecular biology.

[41]  P. Brown,et al.  A nucleoprotein complex mediates the integration of retroviral DNA. , 1989, Genes & development.

[42]  F. Bushman,et al.  Retroviral DNA integration directed by HIV integration protein in vitro. , 1990, Science.

[43]  J. D. den Dunnen,et al.  The PWWP domain: a potential protein–protein interaction domain in nuclear proteins influencing differentiation? , 2000, FEBS letters.

[44]  J. Hoxie,et al.  Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. , 1986, Science.

[45]  J. Boeke,et al.  Complementation of integrase function in HIV‐1 virions , 1997, The EMBO journal.

[46]  A. Wlodawer,et al.  Structure-based inhibitors of HIV-1 protease. , 1993, Annual review of biochemistry.

[47]  Robert Craigie,et al.  HIV-1 DNA integration: Mechanism of viral DNA cleavage and DNA strand transfer , 1991, Cell.

[48]  B. Walker,et al.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.

[49]  J J Goedert,et al.  Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene , 1996, Science.

[50]  R. Shoeman,et al.  A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum , 1993, Journal of virology.

[51]  R. Swanstrom,et al.  Synthesis, Assembly, and Processing of Viral Proteins , 1997 .

[52]  K. Mizuuchi,et al.  A large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration , 1997, The EMBO journal.

[53]  M. Summers,et al.  Structural biology of HIV. , 1999, Journal of molecular biology.

[54]  A. Skalka,et al.  The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro , 1990, Cell.

[55]  A. Engelman,et al.  Nuclear Localization of Human Immunodeficiency Virus Type 1 Preintegration Complexes (PICs): V165A and R166A Are Pleiotropic Integrase Mutants Primarily Defective for Integration, Not PIC Nuclear Import , 2002, Journal of Virology.

[56]  V. Vogt Ubiquitin in retrovirus assembly: actor or bystander? , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[57]  D. Purcell,et al.  Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity , 1993, Journal of virology.

[58]  P. Sharp,et al.  Nuclear import and cell cycle arrest functions of the HIV‐1 Vpr protein are encoded by two separate genes in HIV‐2/SIV(SM). , 1996, The EMBO journal.

[59]  Hideji Nakamura,et al.  Hepatoma-derived growth factor belongs to a gene family in mice showing significant homology in the amino terminus. , 1997, Biochemical and biophysical research communications.

[60]  R. Katz,et al.  Substrate recognition by retroviral integrases. , 1999, Advances in virus research.

[61]  E. Freed,et al.  The Role of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in Virus Infection (*) , 1995, The Journal of Biological Chemistry.

[62]  Ping Wei,et al.  A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA , 1998, Cell.

[63]  R. Desrosiers,et al.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS , 1991, Cell.

[64]  Luc Montagnier,et al.  HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap , 2000, Cell.

[65]  M. Emerman,et al.  A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells , 1993, Nature.

[66]  J. Luban,et al.  Specific incorporation of cyclophilin A into HIV-1 virions , 1994, Nature.

[67]  Jeremy Luban,et al.  Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B , 1993, Cell.

[68]  W. Sundquist,et al.  Assembly and analysis of conical models for the HIV-1 core. , 1999, Science.

[69]  E. De Clercq,et al.  Nuclear localization of human immunodeficiency virus type 1 integrase expressed as a fusion protein with green fluorescent protein. , 1999, Virology.

[70]  T. Klimkait,et al.  A novel gene of HIV-1, vpu, and its 16-kilodalton product. , 1988, Science.

[71]  J. Sodroski,et al.  Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[72]  M. Yamamoto,et al.  A new member of a hepatoma-derived growth factor gene family can translocate to the nucleus. , 1999, Biochemical and biophysical research communications.

[73]  A. Skalka,et al.  The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration , 1989, Journal of virology.

[74]  W. O'brien,et al.  HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain , 1990, Nature.

[75]  P. Brown,et al.  Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[76]  A. D. Clark,et al.  Structure of HIV-1 reverse transcriptase/DNA complex at 7 Å resolution showing active site locations , 1992, Nature.

[77]  J. Skehel,et al.  Structure of influenza haemagglutinin at the pH of membrane fusion , 1994, Nature.

[78]  A. Engelman,et al.  Multiple Integrase Functions Are Required to Form the Native Structure of the Human Immunodeficiency Virus Type I Intasome* , 1999, The Journal of Biological Chemistry.

[79]  M. Martin,et al.  Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation , 1991, Journal of virology.

[80]  V. Pathak,et al.  “Might as Well Jump!” Template Switching by Retroviral Reverse Transcriptase, Defective Genome Formation, and Recombination☆ , 1997 .

[81]  Zeger Debyser,et al.  HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells* , 2003, The Journal of Biological Chemistry.

[82]  D. Thomas,et al.  A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. , 1998, Molecular cell.

[83]  W. Haseltine,et al.  Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[84]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[85]  K. Jeang,et al.  A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[86]  Xiaodong Cheng,et al.  The PWWP domain of mammalian DNA methyltransferase Dnmt3b defines a new family of DNA-binding folds , 2002, Nature Structural Biology.

[87]  J. Sodroski,et al.  The trans-activator gene of the human T cell lymphotropic virus type III is required for replication , 1986, Cell.

[88]  L. Mulder,et al.  Degradation of HIV-1 Integrase by the N-end Rule Pathway* , 2000, The Journal of Biological Chemistry.

[89]  T. Hope,et al.  HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[90]  J. Sodroski,et al.  Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.

[91]  F. Bushman,et al.  Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition , 1997, Journal of virology.

[92]  Robert Craigie,et al.  The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro , 1990, Cell.

[93]  R. Doms,et al.  Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry. , 1997, Virology.

[94]  J. Kappes,et al.  Functional RT and IN incorporated into HIV‐1 particles independently of the Gag/Pol precursor protein , 1997, The EMBO journal.

[95]  B. Berkhout,et al.  Tat trans-activates the human immunodeficiency virus through a nascent RNA target , 1989, Cell.

[96]  M. Muesing,et al.  Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells , 1995, Journal of virology.

[97]  M. Martin,et al.  Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types , 1991, Journal of virology.